stock quotes reflect trades reported through Nasdaq only comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Dividend Yield A company's dividend expressed as a percentage of its current stock price. Restricted stock typically is that issued to company insiders with limits on when it may be traded. To calculate, start with total shares outstanding and subtract the number of restricted shares. Public Float The number of shares in the hands of public investors and available to trade. Shares Outstanding Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public. For companies with multiple common share classes, market capitalization includes both classes. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. Market Capitalization Reflects the total market value of a company. Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Just before the announcement of the acquisition of TerraFarma by Aurora Cannabis, the U.S.-based company Cresco Labs announced to acquire New York-based Columbia Care for $2 billion in an all-stock transaction.īoth announcements have driven consolidation in the cannabis space both in the United States and Canada.P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
The most significant change that Aurora Cannabis stock made is giving Thrive management a head role in operations, including Aurora's recreational business.Īccording to some experts, investors are still unsure that the acquisition may be a massive purchase that Aurora probably can't afford right now. The earnout consideration consists of up to $10 million for satisfying specific near-term revenue targets and up to $20 million for meeting specific long-term revenue targets within two years of the closing of the transaction, according to the transaction details provided by Aurora Cannabis. He added that combining Aurora Cannabis and TerraFarma will be transformative.įollowing the announcement, Aurora Cannada stock, publicly listed in Toronto Stock Exchange and Nasdaq as ACB, jumped 10% before share came back down to 2%.Īlthough Aurora Cannabis will acquire TerraFarma for $38 million in cash and shares, it could pay up to $20 million to Thrive in shares, cash, or both should it reach revenue targets over the next two years and become a profitable acquisition by the first half of 2023. "We are excited to be joining a team that shares our vision for delivering the highest quality, premium cannabis products to consumers in a way that generates sustainable profitability," said Geoff Hoover, CEO of Thrive, in a press statement. "We see a unique opportunity to leverage their expertise to deliver near and long-term benefits for both our recreational and medical markets," he said. In this perspective, the acquisition of TerraFarma meets Aurora Cannabis's criteria as the Thrive teams include cultivators who have gained trust with consumers and developed products that have been recognized and acclaimed by Canadian budtenders and industry players, according to Martin. In a press statement, Miguel Martin, CEO of Aurora, said the company wants to focus on acquiring talent and brands that align with Aurora's path to profitability.
0 kommentar(er)
